DAPK1 and ovarian carcinoma: In addition, ovarian cancer TCGA patients with low stages (I and II) and a high methylation of DAPK1 at the cg22571217 site displayed poor overall survival (log-rank p = 0.007) (Figure 2D), supporting the role of the epigenetic regulation of DAPK1 in ovarian cancer patients.